These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

735 related articles for article (PubMed ID: 23425518)

  • 1. Guideline of transthyretin-related hereditary amyloidosis for clinicians.
    Ando Y; Coelho T; Berk JL; Cruz MW; Ericzon BG; Ikeda S; Lewis WD; Obici L; Planté-Bordeneuve V; Rapezzi C; Said G; Salvi F
    Orphanet J Rare Dis; 2013 Feb; 8():31. PubMed ID: 23425518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary transthyretin-related amyloidosis is frequent in polyneuropathy and cardiomyopathy of no obvious aetiology.
    Skrahina V; Grittner U; Beetz C; Skripuletz T; Juenemann M; Krämer HH; Hahn K; Rieth A; Schaechinger V; Patten M; Tanislav C; Achenbach S; Assmus B; Knebel F; Gingele S; Skrahin A; Hartkamp J; Förster TM; Roesner S; Pereira C; Rolfs A
    Ann Med; 2021 Dec; 53(1):1787-1796. PubMed ID: 34658264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hereditary transthyretin amyloidosis].
    Hund E
    Nervenarzt; 2014 Oct; 85(10):1291-7. PubMed ID: 25123367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transthyretin deposition in familial amyloidotic polyneuropathy.
    Saraiva MJ; Magalhaes J; Ferreira N; Almeida MR
    Curr Med Chem; 2012; 19(15):2304-11. PubMed ID: 22471982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial amyloidotic polyneuropathy and transthyretin.
    Nagasaka T
    Subcell Biochem; 2012; 65():565-607. PubMed ID: 23225017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transthyretin familial amyloid polyneuropathy].
    Kopishinskaya SV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(10):82-89. PubMed ID: 30499502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transthyretin-related familial amyloidotic polyneuropathy.
    Ando Y; Nakamura M; Araki S
    Arch Neurol; 2005 Jul; 62(7):1057-62. PubMed ID: 16009758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm.
    Sekijima Y; Ueda M; Koike H; Misawa S; Ishii T; Ando Y
    Orphanet J Rare Dis; 2018 Jan; 13(1):6. PubMed ID: 29343286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inotersen for the Treatment of Hereditary Transthyretin Amyloidosis.
    Mahfouz M; Maruyama R; Yokota T
    Methods Mol Biol; 2020; 2176():87-98. PubMed ID: 32865784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical diversity, diagnosis and treatment of hereditary amyloid neuropathy].
    Sekijima Y
    Rinsho Shinkeigaku; 2014; 54(12):953-6. PubMed ID: 25672679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary transthyretin-related amyloidosis.
    Finsterer J; Iglseder S; Wanschitz J; Topakian R; Löscher WN; Grisold W
    Acta Neurol Scand; 2019 Feb; 139(2):92-105. PubMed ID: 30295933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transthyretin-related amyloidotic cardiomyopathy: looking for the etiological treatment].
    Longhi S; Gagliardi C; Milandri A; Manuzzi L; Rapezzi C
    G Ital Cardiol (Rome); 2014 May; 15(5):293-300. PubMed ID: 25002169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transthyretin-related familial amyloidotic polyneuropathy-Progress in Kumamoto, Japan (1967-2010)-.
    Araki S; Ando Y
    Proc Jpn Acad Ser B Phys Biol Sci; 2010; 86(7):694-706. PubMed ID: 20689228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ophthalmological manifestations in hereditary transthyretin (ATTR V30M) carriers: a review of 513 cases.
    Beirão JM; Malheiro J; Lemos C; Beirão I; Costa P; Torres P
    Amyloid; 2015; 22(2):117-22. PubMed ID: 26096568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial amyloid polyneuropathy: When does it stop to be asymptomatic and need a treatment?
    Adams D; Beaudonnet G; Adam C; Lacroix C; Théaudin M; Cauquil C; Labeyrie C
    Rev Neurol (Paris); 2016 Oct; 172(10):645-652. PubMed ID: 27663057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings.
    Maia LF; Magalhães R; Freitas J; Taipa R; Pires MM; Osório H; Dias D; Pessegueiro H; Correia M; Coelho T
    J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):159-67. PubMed ID: 25091367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis.
    Gertz MA; Benson MD; Dyck PJ; Grogan M; Coelho T; Cruz M; Berk JL; Plante-Bordeneuve V; Schmidt HHJ; Merlini G
    J Am Coll Cardiol; 2015 Dec; 66(21):2451-2466. PubMed ID: 26610878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.
    Yamamoto H; Hashimoto T; Kawamura S; Hiroe M; Yamashita T; Ando Y; Yokochi T
    J Med Case Rep; 2018 Dec; 12(1):370. PubMed ID: 30553273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wild-type transthyretin significantly contributes to the formation of amyloid fibrils in familial amyloid polyneuropathy patients with amyloidogenic transthyretin Val30Met.
    Tsuchiya-Suzuki A; Yazaki M; Kametani F; Sekijima Y; Ikeda S
    Hum Pathol; 2011 Feb; 42(2):236-43. PubMed ID: 21056899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathy Associated with Systemic Amyloidosis.
    Kaku M; Berk JL
    Semin Neurol; 2019 Oct; 39(5):578-588. PubMed ID: 31639841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.